Cytek Biosciences, Inc. (CTKB)
4.23
+0.24
(+6.02%)
USD |
NASDAQ |
May 28, 15:11
Cytek Biosciences Total Liabilities (Quarterly) : 121.47M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Standard BioTools, Inc. | 77.99M |
| Rapid Micro Biosystems, Inc. | 41.96M |
| Henry Schein, Inc. | 6.482B |
| Accendra Health, Inc. | 2.881B |
| Itonis, Inc. | 1.283M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 449.11M |
| Shareholders Equity (Quarterly) | 327.64M |
| Debt to Equity Ratio | 0.1109 |
| Current Ratio | 4.686 |
| Net Debt Paydown Yield | -0.30% |